Tag: FDA and pharma
FDA Approves Failed Alzheimer’s Drug
The FDA approved Biogen's failed drug aducanumab, overriding the 10-0 recommendation of its own advisory committee. Three panel members resigned in protest.
Statisticians: Current Policies Approve Ineffective Treatments
Current standards for clinical trials rely on statistical methods that allow for ineffective treatments to gain approval.
